PeterWBushunowMD

Oncology • Rochester, NY

Physician

Join to view full profile

Dr. Bushunow is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Bushunow's full profile

Already have an account?

Office
1425 Portland Ave
Rochester, NY 14621
Phone+1 585-922-4200

Fax+1 585-922-4622

Education & Training

SUNY Upstate Medical UniversityFellowship, Hematology and Medical Oncology, 1989 - 1992
SUNY Upstate Medical UniversityResidency, Internal Medicine, 1986 - 1989
Washington University in St. Louis School of MedicineClass of 1986

Certifications & Licensure

NY State Medical License 1987 - 2026
CA State Medical License 2023 - 2025
American Board of Internal Medicine Internal Medicine

Clinical Trials

Radiation Therapy Combined With Chemotherapy in Treating Patients With Anaplastic Astrocytoma or Mixed Gliomas Start of enrollment: 2000 Jun 01
Completed
Phase 3
Buspirone in Reducing Shortness of Breath in Patients With Cancer Start of enrollment: 2002 Nov 01
Completed
Phase 2, Phase 3
Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial) Start of enrollment: 2006 Apr 07
Active, not recruiting
Phase 3
Zometa Adjuvant Treatment of Malignant Pleural Effusion Due To Non-Small Cell Lung Cancer Start of enrollment: 2009 Nov 01
Terminated
Phase 2
Gemcitabine Hydrochloride or Pemetrexed Disodium and Carboplatin With or Without Celecoxib in Treating Patients With Advanced Non-Small Cell Lung Cancer Start of enrollment: 2010 Feb 01
Terminated
Phase 3
A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer Start of enrollment: 2010 Aug 13
Completed
Phase 3
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery Start of enrollment: 2010 Jun 01
Active, not recruiting
Phase 3
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Jan 15
Active, not recruiting
Phase 3
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer Start of enrollment: 2013 Sep 12
Active, not recruiting
Phase 3
Alternative Approaches for Nausea Control Start of enrollment: 2012 Nov 01
Completed
Not Applicable
A Study of Abemaciclib (LY2835219) Combined With Fulvestrant in Women With Hormone Receptor Positive HER2 Negative Breast Cancer Start of enrollment: 2014 Jul 22
Active, not recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

4 citations
Pralatrexate in Combination with Oxaliplatin in Advanced Esophagogastric Cancer: A Phase II Trial with Predictive Molecular Correlates
Usha Malhotra, Sarbajit Mukherjee, Christos Fountzilas, Patrick McKay Boland, Austin Miller
Molecular Cancer Therapeutics. 2020-01-01
6 citations
Positive effects of acupressure bands combined with relaxation music/instructions on patients most at risk for chemotherapy-induced nausea
Anita R. Peoples, Eva Culakova, Charles E. Heckler, Michelle Shayne, Tracey O'Connor
Supportive Care in Cancer. 2019-03-30
13 citations
Racial Differences in Information Needs During and After Cancer Treatment: a Nationwide, Longitudinal Survey by the University of Rochester Cancer Center National Canc...
Matthew Asare, Luke J. Peppone, Joseph A. Roscoe, Ian R. Kleckner, Karen M. Mustian
Journal of Cancer Education. 2018-02-01

Press Mentions

Breast Cancer Study Shows Some Women Can Skip Chemo as Part of Follow-up TreatmentJune 13th, 2018

Professional Memberships

American College of Physicians - ACP
Member
American Society of Clinical Oncology - ASCO
Member